Wuppertal, Germany

Michael Schauer

USPTO Granted Patents = 4 


Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 2005-2011

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Michael Schauer

Introduction

Michael Schauer, a prolific inventor based in Wuppertal, Germany, has made significant contributions to the field of biotechnology. With a remarkable repertoire of four patents to his name, his work focuses primarily on advancing medical diagnostics and treatment options.

Latest Patents

Among his most recent innovations are the Human TIMP-1 antibodies. These groundbreaking human antibodies bind to TIMP-1, serving as essential reagents for diagnosing and treating various disorders where TIMP-1 levels are elevated. Conditions such as liver fibrosis, alcoholic liver disease, cardiac fibrosis, acute coronary syndrome, lupus nephritis, glomerulosclerotic renal disease, benign prostate hypertrophy, colon cancer, lung cancer, and idiopathic pulmonary fibrosis can benefit from Schauer's scientific advancements.

Career Highlights

Michael Schauer has built an impressive career by working with notable companies in the pharmaceutical industry, including Bayer Healthcare and Bayer Corporation. His innovative spirit and dedication have led him to become a recognized figure in biotechnology.

Collaborations

Throughout his career, Schauer has collaborated with esteemed colleagues such as Clark Qun Pan and Andreas Knorr. These partnerships have further propelled his research, leading to his impactful patents.

Conclusion

Michael Schauer stands out as a key inventor whose work is helping to shape the future of medical science. His patents reflect a commitment to addressing serious health issues, showcasing the importance of innovation in the fight against diseases. As he continues to develop new technologies, Schauer’s contributions will undoubtedly have a lasting impact on healthcare and biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…